Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

CREAM, MASSAGE

Active
SPE2DP-26-T-4209Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract is for the procurement of 12 each of a 15-ounce deep tissue massage cream designed for use in therapeutic settings to aid muscle recovery from stress or injury. The product is non-greasy, hypoallergenic, and must comply with FDA regulations as a regulated medical device. Each unit is to be packaged in sealed commercial containers meeting MIL-STD-2073-1E standards, with outer shipping containers ensuring safe transit at the lowest freight cost. Packaging and labeling must adhere strictly to the Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and include required government identification per applicable directives. The item has a non-extendable shelf life of 36 months and is classified as a Type I (Code Q) item. The manufacturer is PERFORMANCE HEALTH SUPPLY, LLC with part number 081285782 and NSN 6508-01-700-7944. Delivery is required within five days of order placement to Rose Barracks in Vilseck, Germany, under FOB Destination terms with zero variance allowed in quantity. The product must be stored at temperatures of 40°F or above and shipped in compliance with DLA packaging and transportation guidelines. The solicitation number is SPE2DP-26-T-4209, with a required delivery date of July 22, 2026, and the contracting officer must submit a referral to the product specialist via EBS for FDA-regulated item confirmation prior to award.

General Info

Procure 12 units of FDA-regulated 15-oz massage cream, deliver by July 22, 2026, to Vilseck, Germany, under strict packaging and storage norms.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

456120 - Cosmetics, Beauty Supplies, and Perfume RetailersView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4209 Medical Supply Chain Pharma FSA

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Parris Sandlin
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
CREAM,MASSAGE
CREAM, MASSAGE
.
SOFT TISSUE MASSAGE CREAM, DEEP TISSUE PREP. IDEAL FOR USE DURING A DEEP
TISSUE MASSAGE, ALLOWING FOR MUSCLES TO RECOVER FROM STRESS OR INJURY;
NON-GREASY; HYPOALLERGENIC; 15 OZ.
.
UNIT OF ISSUE: EACH (15OZ).
.
STORE HEATED GENERAL PURPOSE HEATED 40F AND ABOVE
.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/ . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
..
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
PERFORMANCE HEALTH SUPPLY, LLC 4LL78 P/N 081285782
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4209
SECTION B
PR: 7017544815 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017544815 0001 EA 12.000
NSN/MATERIAL:6508017007944
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W81X9C
0002 CS BN CO A DISTRIBUTI
ROSE BARRACKS BLDG 728 AWCF SSF
SUDLAGER STRASSE
VILSECK 92249
SPE2DP-26-T-4209
SECTION B
PR: 7017544815 PRLI: 0001 CONT’D
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
W81X9C
0002 CS BN CO A DISTRIBUTI
ROSE BARRACKS BLDG 728 AWCF SSF
SUDLAGER STRASSE
VILSECK 92249
DE
MARKFOR
W81X9C
0002 CS BN CO A DISTRIBUTI
ROSE BARRACKS BLDG 728 AWCF SSF
SUDLAGER STRASSE
VILSECK 92249
DE
M/F: (TCN) W81X9C61980057
RDD: 212
PROJ: 9GU TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/22/2026
SPE2DP-26-T-4209 NSN/Part Number: 6508-01-700-7944 Quantity: 12 EA Purchase Request: 7017544815QTY: 12 Delivery: 5 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMIErythromycin Ophthalmic Ointment, USP, is a sterile topical medication containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use as an RX-only product. Each unit is packaged in single-dose tubes containing 3.5 grams of ointment, with a unit of issue consisting of 24 tubes per package. The product has a total shelf life of 36 months, and upon receipt by the first government activity, it must have a minimum of 31 months of remaining shelf life. Storage requirements specify controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and commercial packaging must comply with ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements. The manufacturer is PADAGIS US LLC with NDC 00574-4024-39, and the NSN is 6505-01-189-7090. The contract requires delivery of one package (24 tubes) to Fort Bragg, North Carolina, within 20 days of issuance, with FOB destination and zero tolerance for quantity variance. Delivery must be made via traceable freight methods, excluding parcel post, and packaging must meet all DLA procurement standards including palletization and hazardous material handling per FED-STD-313 where applicable. The item falls under a Type I (Code Q) shelf-life category with a non-extendable 36-month lifespan. The contracting official must submit a referral via EBS to confirm product compliance with FDA regulations, including manufacturer and part number details. The solicitation, issued under SPE2DP-26-T-4260, was posted on July 23, 2026, with a response deadline of July 29, 2026, and the required delivery date is July 14, 2026. All documentation, labeling, and marking must align with DLA’s current technical and quality requirements, and the point of contact for inquiries is James McCullough.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
DIBBS
LORATADINE TABLETSLoratadine tablets 10 mg are being procured in quantities of 2 business units, with each unit containing 500 tablets, for a total of 1,000 tablets under contract SPE2DP-26-T-4248. The product must comply with all technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, including packaging and marking standards specified in Medical Marking Standard No. 1, which replaces MIL-STD-129. Packaging must be commercial-grade, with each unit sealed in a container that protects against damage and breakage, and shipped in exterior containers suitable for safe delivery via common carrier at the lowest cost to the destination point. The item is regulated by the FDA and requires storage between 20°C and 25°C (68°F to 77°F), protected from excessive moisture. It has a non-extendable shelf life of 36 months, classified as a TYPE I (CODE Q) item under DLA shelf-life requirements. The manufacturer is OHM Laboratories Inc. with NDC 51660-0526-05, and the distributor is AmerisourceBergen Drug Corp. Delivery is FOB destination within 20 days of contract award with zero tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The NSN is 6505-01-524-9179, and all markings must adhere to the latest MMS No. 1 guidelines available through DLA Troop Support. The contracting official must submit a referral in EBS with manufacturer and bidder details prior to award.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 423450
New
DIBBS
OMEPRAZOLE EXTENDED-REThe contract specifies the procurement of 20 mg omeprazole extended-release capsules in 90-count bottles, identified by NSN 6505016247068 and NDC 00781-2868-92, manufactured by Sandoz Inc. Each unit must be packaged in sealed commercial containers that protect against damage, with shipping containers meeting commercial standards for safe delivery at the lowest freight rate. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must adhere to DLA’s Packaging Requirements. The product has a 24-month shelf life, with at least 21 months remaining at the time of delivery to the first government activity. All units are subject to strict DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951, and must be shipped via the fastest traceable means—parcel post is prohibited. The drug is FDA-regulated, and bidders must be referred for product specialist confirmation. Deliveries are split across multiple locations including Fort Stewart, Georgia and Fort Campbell, Kentucky, with rigid zero variance in quantity and fixed delivery dates in July 2026. Inspection and acceptance occur at destination, with all markings and documentation required to align with government-specific identifiers and freight instructions provided in full detail for each delivery point.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
DIBBS
DEXAMETHASONE TABLETSThe contract pertains to the procurement of Dexamethasone Tablets, USP, 0.5 mg, in unit dose packaging under the National Stock Number 6505-01-045-0451, with a total quantity of 2 packaging groups, each equivalent to 100 tablets. The supplier must adhere to strict packaging and labeling requirements as defined by Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed in protective containers to ensure integrity during shipment. The product, manufactured by Roxane Labs or Hikma Pharmaceuticals USA Inc. under NDC 00054-8179-25, is regulated by the FDA and requires confirmation via EBS referral. It carries a non-extendable shelf life of 36 months and must be marked in full compliance with the latest Medical Marking Standard. Delivery is required FOB destination within five days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the destination point. The solicitation is issued under SPE2DP-26-T-4266, with a response deadline of July 29, 2026, and the sole point of contact is James Foggie at DLA Troop Support, with performance directed to Fort Bragg, NC, 28310.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION LACTATED USP in 1000 mL units, packaged 12 per pack (1 PG), is procured under contract SPE2DP-26-T-4258 with a total quantity of 21 packs to be delivered within 20 days FOB destination. The product is regulated by the FDA and carries a non-extendable shelf life of 30 months as a TYPE I (CODE P) item. Packaging must comply with Medical Marking Standard No. 1, replacing all prior references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Units must be packed in commercial exterior shipping containers suitable for safe delivery at the lowest carrier rate, with labeling and marking strictly following the latest version of MMS No. 1. The product must be stored at room temperature (25°C), with brief exposure up to 40°C permitted without adverse effects, and must be protected from freezing and excessive heat. The manufacturer is B. BROWN MEDICAL INC with NDC number 00264-7750-00 and part number L7500. Inspection and acceptance occur at the delivery point with zero variance allowed in quantity. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with applicable revisions controlled by the solicitation or award date. Government identification must be removed from non-accepted supplies per RQ011, and procurement is subject to covered defense information provisions. Delivery is to Fort Bragg, NC, with primary point of contact Timothy McCauley at DLA.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 424210
New
DIBBS
IOHEXOL INJECTIONIOHEXOL INJECTION, USP at 300 mg per milliliter in 150 mL polymer bottles, is being procured in boxes of ten bottles each, with a total quantity of 24 boxes required under contract SPE2DP-26-T-4252. The product is classified as a radiological contrast media and must be stored at controlled room temperature between 20–25°C (68–77°F), with excursions permitted between 15–30°C (59–86°F), and must be protected from strong daylight and direct sunlight and not frozen. It carries a non-extendable shelf life of 36 months and must be packaged and marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed and protected against damage, and shipped in commercial exterior containers suitable for safe transport via common carrier at the lowest cost to the designated delivery point at Fort Bragg, North Carolina. The item is subject to Hazard Communication Standard requirements, necessitating Safety Data Sheets aligned with 29 C.F.R. 1910.1200 and compliant labeling prior to award, along with employee training on the updated standards. Packaging must conform to DLA’s RP001 requirements and federal hazardous material guidelines, and if classified as hazardous under Fed-Std-313, must follow TQ requirement IP025; otherwise, commercial packaging per ASTM D3951 applies, though DLA’s technical requirements take precedence. Delivery is required within five days of order placement, FOB destination, with no variance allowed in quantity. The product is supplied by GE HEALTHCARE INC, identified by NDC 00407-1413-65, and must be shipped by the fastest traceable means, excluding parcel post. The required delivery date is July 24, 2026, with solicitation responses due by July 29, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 456199
New
DIBBS
KETAMINE INJECTION, VETKetamine Hydrochloride Injection, USP, in 10 mL multiple-dose vials, is a DEA Schedule C-III controlled substance classified for veterinary use, subject to strict handling and storage requirements including storage in a vault at medically controlled room temperature. The item is regulated by the FDA and must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, with all packaging and labeling aligned to DLA’s Packaging Requirements for Procurement RP001. The product carries a non-extendable 24-month shelf life under RS016 requirements, and each unit must be sealed in commercial-grade containers capable of preventing damage, with palletization and exterior packaging conforming to DLA standards for safe transport via common carrier. Deliveries are required FOB destination within 89 days of contract award, with no tolerance for quantity variance, and must be shipped to the specified military medical logistics hub in Kaiserslautern, Germany, or to APO AE 09227-0000, with inspection and acceptance occurring at the delivery point. The contract, identified by solicitation number SPE2DP-26-T-4257 and NSN 6509-01-712-2920, is issued by the Department of Defense under the Medical Supply Chain Pharm FSA, requiring precise adherence to federal procurement and pharmaceutical handling protocols. The item is procured in a single unit of issue, with a required delivery date of July 23, 2026, and response deadline of July 29, 2026. Only approved vendors—Patterson Veterinary Supply, Inc., Covetrus North America, LLC, and Zoetis Inc.—with authorized part numbers may submit bids. All submissions must include manufacturer details and product specifications for FDA referral via EBS, and the item is subject to Covered Defense Information protocols under RD003. Commercial packaging is mandated, with no government identification to be removed from non-accepted supplies per RQ011, and all markings must conform to the latest Medical Marking Standard No. 1 as published by DLA Troop Support.
All Other Health and Personal Care Retailers

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
DIBBS
ALBUMIN HUMANALBUMIN HUMAN USP 25% in 50 mL vials is specified for intravenous use only, with a concentration of 25% volume to volume, and is heat treated with included administration accessories such as 18 or 20 gauge needles. Each unit must be free of turbidity and stored at room temperature, with no freezing allowed. The product has a non-extendable shelf life of 36 months and is classified as a TYPE I (CODE Q) item under shelf-life requirements. It is regulated by the FDA, and buyers must ensure proper referral through EBS to confirm bidder and manufacturer details, including NDC numbers for KEDRION BIOPHARMA INC and GRIFOLS USA LLC. Packaging must comply with Commercial standards as specified in the procurement document, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be contained in sealed, protective unit containers within suitable commercial shipping containers to ensure safe, low-cost delivery to the destination point. All units must be marked and packaged according to MIL-STD-2073-1E, and the material is subject to RD003 covered defense information provisions. The contract calls for a delivery of exactly 10 packs, each containing one 50 mL vial, totaling 500 mL, to be delivered within five days FOB destination with zero variance allowed. Inspection and acceptance occur at the destination. The solicitation number is SPE2DP-26-T-4249, issued by the Department of Defense’s Medical Supply Chain, with a response deadline of July 29, 2026, and performance is designated for Fort Bragg, NC.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR INJECTIONThe contract specifies the procurement of 10 packages of Water for Injection, Sterile, USP, each package containing 25 sterile 20 mL vials with flip-top closures, for a total of 250 vials. The product must comply with USP standards and be labeled in accordance with the latest Medical Marking Standard No. 1, with packaging conforming to MIL-STD-2073-1E. Storage requirements mandate controlled room temperature between 20 and 25 degrees Celsius, and the item has a non-extendable shelf life of 24 months as per RS016 and RS001 for a Type I (Code M) item. The delivery is FOB destination within 20 days of contract award with zero variance allowed in quantity, and inspection and acceptance occur at the destination. The item is regulated by the FDA, and buyers must submit a referral through EBS including manufacturer and bidder details. Only two approved manufacturers are listed: Hospira Worldwide LLC with NDC 00409-4887-20 and Fresenius Kabi, LLC with NDC 63323-0185-20. The contract is issued under solicitation SPE2DP-26-T-4261, with a response deadline of July 29, 2026, and the NSN is 6505-00-582-5079. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, and provisions for removal of government identification from non-accepted supplies and potential covered defense information apply.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, UThe contract specifies the procurement of TOLNAFTATE POWDER USP 1% in 45 gram units, identified by NSN 6505014807897 and NDC 57896-0199-45, supplied by GERI-CARE PHARMACEUTICALS CORP. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months and must be packaged in compliance with the DLA Master List of Technical and Quality Requirements, superseding all other standards including ASTM D3951 and MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packages suitable for safe delivery via common carrier at the lowest cost, marked in accordance with Medical Marking Standard No. 1, which replaces all prior military marking requirements. The unit of issue is BT, where one BT equals 45 grams, and each shipment must adhere to strict palletization and labeling guidelines outlined in RP001 and other referenced DLA technical directives. The contract includes three separate line items totaling 28 BT (1,260 grams), with delivery deadlines of July 23, 2026, for 24 BT destined to FPO AP 96694, July 27, 2026, for 3 BT to VILSECK, Germany, and one BT to an unspecified location. All deliveries are FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring upon arrival. Shipment must occur via the fastest traceable means, explicitly prohibiting parcel post, and must comply with hazardous material handling requirements per FED-STD-313 and IP025 if applicable. The contract is issued under solicitation SPE2DP-26-T-4256, with a five-day delivery window, and all packaging and labeling requirements must reflect the latest DLA medical standards, ensuring full traceability, regulatory compliance, and readiness for military medical use.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 456199
New
DIBBS
MAROPITANT CITRATEMaropitant Citrate 160 mg tablets are supplied in blister packs of four tablets per package, with the unit of issue being a package (PG) of four tablets. The product is a veterinary drug regulated by the FDA and must be stored at controlled room temperature between 20–25°C (68–77°F), with allowable excursions between 15–30°C (59–86°F). It has a non-extendable shelf life of 36 months and must be marked and packaged in strict compliance with the latest Medical Marking Standard No. 1, MIL-STD-129, and ASTM D3951, with DLA Master List of Technical and Quality Requirements taking precedence. Packaging must adhere to DLA procurement requirements, including palletization standards, and must not use parcel post; traceable shipping methods are mandatory. The sole delivery point is Fort Sam Houston, Texas, with a delivery window of 20 days and a required delivery date of July 22, 2026. Quantity is fixed at four packages with no variance permitted. Approved suppliers include Patterson Veterinary Supply, Covetrus North America, and Zoetis Inc., each identified by specific part and NDC numbers. All supplies are subject to inspection and acceptance at the destination, and government use only markings apply. The solicitation is issued under contract number SPE2DP-26-T-4255 by the Department of Defense, Medical Supply Chain PHARM FSA.
All Other Health and Personal Care Retailers

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 423450
New
DIBBS
SODIUM CHLORIDE INJSodium Chloride Injection in 10 mL disposable syringes, preservative-free and latex-free, is being procured under solicitation SPE2DP-26-T-4254 with a unit of issue of PG, where one PG equals 30 syringes per tray. The product must comply with stringent DLA packaging and marking standards, specifically Medical Marking Standard No. 1, superseding MIL-STD-129, and must be commercially packaged in sealed unit containers to prevent damage or breakage, with exterior shipping containers ensuring safe and cost-effective delivery to Fort Bliss, Texas. The item is regulated by the FDA and requires referral through EBS for confirmation, with no tolerance for quantity variance—exactly one PG must be delivered. The shelf life is strictly 24 months non-extendable and must be clearly marked per MMS No. 1, which is available online through DLA's logistics portal. The delivery is FOB destination with a 20-day lead time from solicitation award, and shipment must occur via traceable freight methods, excluding parcel post. The material is not classified as hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951 unless overridden by higher-priority DLA technical requirements. Palletization must conform to RP001 DLA Packaging Requirements, and labeling must include all mandated information per MMS No. 1, including the manufacturer part number 106346 from AmerisourceBergen Drug Corp. The contract specifies the delivery point as W8001Z, 0142 CS BN CO A Composite, Fort Bliss, TX, with an original required delivery date of July 27, 2026, and the solicitation closed on July 29, 2026. All technical, quality, and packaging specifications take precedence over commercial standards, and compliance is mandatory for acceptance.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

3 days ago

DEADLINE

in 3 days
View Details